We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GKOS market cap is 5.78B. The company's latest EPS is USD -2.5876 and P/E is -39.48.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.37M | 85.62M | 95.69M | 96.67M | 105.5M |
| Operating Income | -38.62M | -39.07M | -29.97M | -24.66M | -28.67M |
| Net Income | -36.78M | -40.84M | -50.55M | -21.41M | -33.58M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 224.96M | 294.01M | 282.86M | 314.71M | 383.48M |
| Operating Income | -123.55M | -62.87M | -113.21M | -128.7M | -122.37M |
| Net Income | -120.35M | -49.59M | -100.1M | -134.66M | -146.37M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 940.41M | 933.34M | 919.68M | 926.54M | 974.76M |
| Total Liabilities | 478.65M | 482.61M | 254.52M | 258.03M | 207.83M |
| Total Equity | 461.77M | 450.73M | 665.16M | 668.51M | 766.93M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.01B | 1.05B | 1B | 940.41M | 974.76M |
| Total Liabilities | 338.05M | 462.55M | 472.38M | 478.65M | 207.83M |
| Total Equity | 667.45M | 587.15M | 530.01M | 461.77M | 766.93M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57.76M | -33.87M | -52.24M | -61.83M | -61.32M |
| Investing | 14.1M | -29.38M | 5.48M | 36.04M | 47.83M |
| Financing | 15.04M | 13.17M | 21.76M | 31.43M | 91.54M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.99M | 24.71M | -33.08M | -57.76M | -61.32M |
| Investing | -205.06M | -58.23M | 44.78M | 14.1M | 47.83M |
| Financing | 262.54M | 39.26M | 6.25M | 15.04M | 91.54M |
| Market Cap | 5.78B |
| Price to Earnings Ratio | -39.48 |
| Price to Sales Ratio | 15.07 |
| Price to Cash Ratio | 34.06 |
| Price to Book Ratio | 7.53 |
| Dividend Yield | - |
| Shares Outstanding | 56.57M |
| Average Volume (1 week) | 1.44M |
| Average Volume (1 Month) | 1.35M |
| 52 Week Change | 17.45% |
| 52 Week High | 161.78 |
| 52 Week Low | 84.08 |
| Spread (Intraday) | 4.52 (4.35%) |
| Company Name | Glaukos Corporation |
| Address |
1201 north market st fl wilmington, delaware 19801 |
| Website | https://www.glaukos.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
